The role of fetal FTO risk variants in the regulation of maternal glucose metabolism during pregnancy and its subsequent contribution to obesity risk in adulthood needs to be further explored. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.